Pacira BioSciences Inc (PCRX)
16.57
-0.03
(-0.18%)
USD |
NASDAQ |
Nov 01, 16:00
16.55
-0.02
(-0.12%)
After-Hours: 20:00
Pacira BioSciences Market Cap: 764.32M for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 764.32M |
| October 31, 2024 | 765.71M |
| October 30, 2024 | 778.16M |
| October 29, 2024 | 792.46M |
| October 28, 2024 | 790.15M |
| October 25, 2024 | 776.32M |
| October 24, 2024 | 785.08M |
| October 23, 2024 | 801.69M |
| October 22, 2024 | 813.22M |
| October 21, 2024 | 799.38M |
| October 18, 2024 | 806.76M |
| October 17, 2024 | 781.85M |
| October 16, 2024 | 767.09M |
| October 15, 2024 | 769.86M |
| October 14, 2024 | 752.79M |
| October 11, 2024 | 748.18M |
| October 10, 2024 | 715.43M |
| October 09, 2024 | 718.66M |
| October 08, 2024 | 722.35M |
| October 07, 2024 | 737.57M |
| October 04, 2024 | 761.79M |
| October 03, 2024 | 732.96M |
| October 02, 2024 | 716.35M |
| October 01, 2024 | 705.74M |
| September 30, 2024 | 694.21M |
| Date | Value |
|---|---|
| September 27, 2024 | 670.69M |
| September 26, 2024 | 661.00M |
| September 25, 2024 | 641.63M |
| September 24, 2024 | 657.77M |
| September 23, 2024 | 658.69M |
| September 20, 2024 | 670.22M |
| September 19, 2024 | 677.60M |
| September 18, 2024 | 675.76M |
| September 17, 2024 | 661.69M |
| September 16, 2024 | 622.25M |
| September 13, 2024 | 604.72M |
| September 12, 2024 | 587.20M |
| September 11, 2024 | 599.65M |
| September 10, 2024 | 611.18M |
| September 09, 2024 | 610.26M |
| September 06, 2024 | 638.86M |
| September 05, 2024 | 677.14M |
| September 04, 2024 | 698.36M |
| September 03, 2024 | 700.21M |
| August 30, 2024 | 717.73M |
| August 29, 2024 | 708.51M |
| August 28, 2024 | 687.29M |
| August 27, 2024 | 667.92M |
| August 26, 2024 | 667.92M |
| August 23, 2024 | 654.54M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
539.68M
Minimum
Aug 09 2024
3.679B
Maximum
Apr 08 2022
2.096B
Average
2.091B
Median
Market Cap Benchmarks
| Cyclo Therapeutics Inc | 20.71M |
| Revance Therapeutics Inc | 604.25M |
| NovaBay Pharmaceuticals Inc | 3.664M |
| Palatin Technologies Inc | 23.46M |
| iBio Inc | 23.06M |
Market Cap Related Metrics
| PE Ratio | 12.46 |
| PS Ratio | 1.342 |
| Price to Book Value | 0.8693 |
| Price to Free Cash Flow | 5.016 |
| Price | 16.57 |
| Earnings Yield | 8.03% |
| Operating PE Ratio | 9.162 |
| Normalized PE Ratio | 12.46 |